Devices › Needle, hypodermic, single lumen
Device brand name · Needle hypo rw 30gx1/2
McKesson Brands: medical device reports filed with FDA
397 reports name it, 2019–2026. Manufacturer given most often on reports: Jiangsu Caina Medical. Product code FMI.
- 397
- device reports naming the brand
- 0% of all MAUDE reports · about 55 a year
- 75
- reports, 12 months to August 2026
- 85 in the 12 months before
- 83.1%
- classified as malfunction
- 87.6% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 397 reports that name the brand "McKesson Brands" (needle hypo rw 30gx1/2), received between May 2019 and August 2026; the manufacturer given most often on reports is Jiangsu Caina Medical. Spellings of one product vary from report to report.
75 reports arrived in the 12 months to August 2026, down 12% from 85 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (83.1%), injury (16.6%) and other (0.3%); across all needle, hypodermic, single lumen reports (product code FMI) death is recorded in 0.2% and malfunction in 87.6%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are leak/splash (25.9%), fail-safe problem (18.1%) and partial blockage (9.3%). The patient problems coded most often are needle stick/puncture, foreign body in patient and appropriate clinical signs, symptoms and conditions term/code not available. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 39,876 reports carrying product code FMI. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Leak/splashthe device leaked | 103 | 25.9% | 8.5% |
| Fail-safe problem | 72 | 18.1% | 0.7% |
| Partial blockage | 37 | 9.3% | 0.4% |
| Breakthe device broke | 31 | 7.8% | 12.7% |
| Crackthe device cracked | 30 | 7.6% | 1% |
| Detachment of device or device componentpart of the device came off | 28 | 7.1% | 2.7% |
| Device contaminated during manufacture or shipping | 20 | 5% | 0.2% |
| Complete blockage | 17 | 4.3% | 8.5% |
| Loose or intermittent connection | 14 | 3.5% | 0.5% |
| Material puncture/hole | 11 | 2.8% | 0.5% |
| Difficult to removethe device was hard to remove | 10 | 2.5% | 1.2% |
| Material twisted/bent | 9 | 2.3% | 1.3% |
| Insufficient device problem information | 8 | 2% | 0.5% |
| Dull, blunt | 6 | 1.5% | 0.5% |
| Fluid/blood leak | 6 | 1.5% | 3.3% |
| Material integrity problema problem with the device material | 5 | 1.3% | 0.3% |
| Incomplete or inadequate connection | 3 | 0.8% | 0.2% |
| Material separation | 3 | 0.8% | 1.2% |
| Patient-device incompatibilitythe device did not suit the patient | 3 | 0.8% | 0.2% |
| Separation problem | 3 | 0.8% | 0.6% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Needle stick/puncture | 27 | 6.8% |
| Foreign body in patientpart of a device left in the patient | 15 | 3.8% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 4 | 1% |
| Bacterial infectiona bacterial infection | 4 | 1% |
| Hypersensitivity/allergic reaction | 4 | 1% |
| Blistera blister | 3 | 0.8% |
| Eye injury | 3 | 0.8% |
| Partial thickness (second degree) burn | 3 | 0.8% |
| Skin tears | 3 | 0.8% |
| Abscessa collection of pus | 1 | 0.3% |
| Air embolism | 1 | 0.3% |
| Burning sensationa burning feeling | 1 | 0.3% |
| Chemical exposure | 1 | 0.3% |
| Coughcough | 1 | 0.3% |
| Erythemaskin redness | 1 | 0.3% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | McKesson Brands | Product code FMI | All MAUDE reports |
|---|---|---|---|
| Reports | 397 | 39,876 | 26,136,888 |
| Share of that pool | — | 1% | 0% |
| Classified as death, per 1,000 reports | 0 | 2 | 9 |
| Classified as injury | 16.6% | 10.5% | 36.2% |
| Classified as malfunction | 83.1% | 87.6% | 62.3% |
| Filed by the manufacturer | 8.1% | 92.1% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code FMI
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Unspecified Bd Pen Needle | 1,820 | 0 | 0.1% |
| BD Vacutainer Eclipse Blood Collection Needle | 2,116 | 627 | 0% |
| Bd Safetyglide Needle | 1,258 | 3 | 0% |
| Bd Precisionglide Needle | 1,229 | 0 | 0% |
| Bd Nano 2nd Gen Pen Needle | 788 | 0 | 0% |
| Bd Ultra Fine Pen Needles | 656 | 0 | 0% |
| Pen Ndl 32g 4mm Pro 100 Box 1200 Us | 510 | 9 | 0% |
| BD SafetyGlide | 576 | 127 | 0% |
| Ez-Io Power Driver | 463 | 0 | 2.2% |
| BD Vacutainer Eclipse Blood Collection Needle with Pre-Attached Holder | 423 | 18 | 0% |
| Bd Ultra Fine Pen Needle | 375 | 0 | 0% |
| Bd Safetyglide Needle Only 25 G | 328 | 0 | 0% |
| Unspecified Bd Needle | 327 | 0 | 0% |
| Bd Ultra-Fine Pen Needle | 320 | 0 | 0% |
| Magellan | 330 | 20 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about McKesson Brands reports
How many FDA reports name McKesson Brands?
397 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 75 in the latest 12 months.
What kinds of events are reported?
malfunction (83.1%), injury (16.6%) and other (0.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
leak/splash (25.9%), fail-safe problem (18.1%), partial blockage (9.3%), break (7.8%) and crack (7.6%). These are FDA's device problem codes as entered on the report.
Who files these reports?
distributor reports (91.4%), manufacturer reports (8.1%) and voluntary reports (0.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that McKesson Brands was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.